| Robin Yoshiko Jenkins-semple, DO | |
|
11059 E Bethany Dr, Suite 200, Aurora, CO 80014-2622 | |
| (303) 617-2300 | |
| Not Available |
| Full Name | Robin Yoshiko Jenkins-semple |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 11059 E Bethany Dr, Aurora, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619174042 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 43698 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robin Yoshiko Jenkins-semple, DO 301 Fairfax St, Denver, CO 80220-5746 Ph: (303) 316-7777 | Robin Yoshiko Jenkins-semple, DO 11059 E Bethany Dr, Suite 200, Aurora, CO 80014-2622 Ph: (303) 617-2300 |
News Archive
The inclusion in the House health reform bill of an anti-abortion amendment sponsored by Michigan Democratic Rep. Bart Stupak is causing division and debate among Democrats. Politico reports: "House passage of a sweeping anti-abortion amendment has set off a wave of soul-searching and finger-pointing among abortion rights activists — many of whom thought they'd found a safe harbor when Democrats won the White House and big majorities in Congress last year."
Application Security, Inc., the leading provider of database security, risk and compliance solutions for the enterprise, today announced that Humana Inc. has successfully implemented DbProtect™ to manage and safeguard the highly sensitive, critical information stored on its database servers.
Janssen-Cilag International NV announced today that the European Commission has approved the use of VELCADE (bortezomib) as induction therapy (a first therapeutic option) in combination with dexamethasone or thalidomide and dexamethasone. This licence extension will apply to adult patients with previously-untreated multiple myeloma who are eligible for high-dose chemotherapy with haematological stem cell transplantation.
Merck & Co., Inc., known as MSD outside the United States and Canada, and Pfizer Inc. today announced that they have entered into a worldwide (except Japan) collaboration agreement for the development and commercialization of Pfizer's ertugliflozin (PF-04971729), an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes.
› Verified 8 days ago
Lea C Watson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1890 N Revere Ct, Aurora, CO 80045 Phone: 720-848-0000 | |
Robert House, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Ann Olincy, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Paul Moe, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Erin Schwarz, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1537 Alton St, Aurora, CO 80010 Phone: 303-617-2300 | |
Robert Clyman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Bishara Bhasi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |